{"protocolSection":{"identificationModule":{"nctId":"NCT04775147","orgStudyIdInfo":{"id":"CRISIS I"},"organization":{"fullName":"Nanjing First Hospital, Nanjing Medical University","class":"OTHER"},"briefTitle":"Intensive Control of Blood Pressure in Acute Ischemic Stroke After Endovascular Therapy on Clinical Outcome (CRISIS I)","officialTitle":"Intensive Control of Blood Pressure in Acute Ischemic Stroke After Endovascular Therapy on Clinical Outcome:A Prospective Multicenter Randomized Controlled Trial (CRISIS I)"},"statusModule":{"statusVerifiedDate":"2022-04","overallStatus":"TERMINATED","whyStopped":"Results of ENCHANTED have been published.","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2020-07-03","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2023-01-03","type":"ACTUAL"},"completionDateStruct":{"date":"2023-01-03","type":"ACTUAL"},"studyFirstSubmitDate":"2021-02-25","studyFirstSubmitQcDate":"2021-02-26","studyFirstPostDateStruct":{"date":"2021-03-01","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-07-21","lastUpdatePostDateStruct":{"date":"2023-07-24","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Nanjing First Hospital, Nanjing Medical University","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"CRISIS I is a prospective, multicenter, randomized controlled trial, to asses the impact of intensive blood pressure control on clinical outcome of acute ischemic stroke patients with successful recanalization after endovascular therapy.","detailedDescription":"CRISIS I aims to determine the effectiveness of more intensive BP lowering target (\\<120 mmHg) compared to standard BP management target (\\<140mmHg) on functional outcome in patients with successful recanalization post-MT for AIS due to anterior circulation large vessel occlusion (LVO)."},"conditionsModule":{"conditions":["Acute Ischemic Stroke"],"keywords":["Mechanical thrombectomy","Blood pressure management"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"SINGLE","maskingDescription":"Open intervention; outcome assessments undertaken by trained research staff who are kept blind to treatment allocation","whoMasked":["OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":205,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Intervention group","type":"EXPERIMENTAL","description":"Achieving SBP level of \\<120mmHg within 1 hour after successful recanalization, and maintaining this level at least 72 hours.","interventionNames":["Other: Intensive BP lowering"]},{"label":"Control group","type":"NO_INTERVENTION","description":"Maintaining SBP level of \\<140mmHg within 1 hour after successful recanalization, and maintaining this level at least 72 hours."}],"interventions":[{"type":"OTHER","name":"Intensive BP lowering","description":"The aim is to achieve a systolic BP level of \\<120mmHg within 1hour after successful recanalization and to maintain this BP level for the next 72 hours (or until hospital discharge or death of this should occur earlier)","armGroupLabels":["Intervention group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Level of disability","description":"a shift (improvement) in scores (0-6) on the modified Rankin scale","timeFrame":"90 days (3months)"}],"secondaryOutcomes":[{"measure":"Intracerebral hemorrhage","description":"Any or symptomatic ICH (sICH) after endovascular therapy","timeFrame":"90 day"},{"measure":"Death or neurological severity","description":"Death or dependency measured by National Institutes of Health stroke scale (NIHSS)","timeFrame":"7 days"},{"measure":"BP lowering target (<120 mmHg)","timeFrame":"3 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age ≥18 years\n* Diagnosis of AIS with anterior circulation LVO confirmed by brain imaging\n* To receive MT \\<24 hours after AIS onset according to local guidelines\n* Successful recanalization (TICI score ≥2b) after MT\n* Sustained systolic BP ≥140 mmHg (defined as 2 successive readings \\<10 mins) within 60 minutes after recanalization\n* Provide written informed consent (or approved surrogate)\n* Perform CTA or MRI before endovascular therapy\n* Signed an approved informed consents\n\nExclusion Criteria:\n\n* Significant pre-stroke disability (mRS scores 2-5)\n* Definite indication/contraindication to different intensities of BP lowering treatment\n* Specific contraindications to any of the BP agents to be used (eg, patients who are hypersensitive (allergic) to any of the ingredients)\n* Unlikely to potentially benefit from therapy (e.g. advanced dementia) or very high likelihood of death within 24 hours post-MT, judged by responsible treating clinician\n* Other medical illness that interferes with outcome assessments and follow-up (e.g.advance cancer and renal failure); Women who are lactating\n* Other conditions inappropriate for inclusion judged by investigators","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"locations":[{"facility":"Nanjing First Hospital, Nanjing Medical University","city":"Nanjing","state":"Jiangsu","zip":"210006","country":"China","geoPoint":{"lat":32.06167,"lon":118.77778}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"browseLeaves":[{"id":"M4544","name":"Benzocaine","relevance":"LOW"},{"id":"T433","name":"Tannic Acid","relevance":"LOW"}],"browseBranches":[{"abbrev":"CNSDep","name":"Central Nervous System Depressants"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"Ot","name":"Other Dietary Supplements"}]}},"hasResults":false}